Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Zalvia Pharma Consulting AB
AB
Active
Org 5567424287
Korsängen 61, 433 63
Sävedalen
Business and other management consultancy activities
· NACE 7020
Est. 2007
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Zalvia Pharma Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
676
0
−0
0
0
Staff expenses
—
—
−0
—
—
EBITDA
11
79
−31
−38
−30
Depreciation & amort.
−0
−0
—
−0
−0
EBIT
11
79
−31
−38
−30
Net financials
—
—
1
9
5
Profit before tax
43
143
105
82
48
Tax
−10
−31
−24
−19
−12
Net profit
33
112
81
63
36
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 001
677
539
404
285
Equity
446
258
239
212
198
Long-term debt
0
0
—
0
0
Short-term debt
103
32
48
52
20
Total debt
103
32
48
52
20
Financial ratios
5-year trend
EBITDA margin
-3000000.0%
This company
15.8%
Market median
-18987442% vs market
2020
2024
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
2020
2024
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
2020
2024
Net profit margin
3600000.0%
This company
8.1%
Market median
+44444344% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Zalvia Pharma Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
